The coronavirus pandemic affected everyone, but some of us faced an outsized share of disruption.
coronavirus
Posted inFood
These 10 food trends were the distractions we needed in 2020
Social media ruled when it comes to telling us what crazy thing to cook or bake.
advertisement
Posted inOp-eds, Opinion
Commentary: Los Angeles locked down, but COVID came anyway
The city’s crisis contradicts the simple narrative that outbreaks are punishment for red-state recklessness.
Posted inBusiness, Local & State
Push for COVID research drives $9.5 million funding increase for Jackson Lab
The Bar Harbor-based institution landed more than $100 million in funding from more than 200 grants this year, much of it for projects related to COVID-19.
Posted inNation & World
Death of congressman-elect with COVID-19 stuns Louisiana politicians
Luke Letlow, 41, who had no known underlying health conditions, died just days before he was scheduled to be sworn into office.
Posted inLocal & State, News
Sunday River Brewing Co. owners seek court reversal of license nonrenewal
After a renewal of the restaurant’s license to operate was rejected this week, the Savage brothers are back in court in an effort to overturn the decision.
Posted inLocal & State, News
Maine Acts of Kindness: Feeding the frontline workers is as important as ever
With COVID-19 cases surging, local restaurants are once again providing meals to health care workers and first responders – and keeping their lights on.
Posted inHealth, Local & State
Vaccine one more defense for workers on frontlines of COVID-19
EMS workers such as those employed by Waterville-based Delta Ambulance now have a way of protecting themselves from infection as well as protecting their patients.
Posted inTimes Record
Midcoast Hospital rolls out Moderna vaccine
The recent shipment of the Moderna vaccine, coupled with the existing doses of the Pfizer, will allow the remaining patient-facing staff in the agency’s practices and home care clinics to be immunized.
Posted inBusiness, Nation & World
Chinese drugmaker: Vaccine 79.3% effective in final tests
Sinopharm is one of at least five Chinese developers that are in a global race to create vaccines for the disease that has killed more than 1.7 million people.